Autophagy, new perspectives in anticancer therapy;Autofagia, nowe perspektywy w terapii przeciwnowotworowej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 925-935

  Lisiak, Natalia ^a   Totoń, Ewa ^a   Rybczyńska, Maria ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Autophagy; Cancer; Targeted therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; AUTOPHAGY; CELL SURVIVAL; DRUG DESIGN; DRUG EFFECTS; HUMAN; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CELL SURVIVAL; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84920552947     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1111361     Document Type: Review

References (81)

1. Alinari L., Yu B., Christian B.A., Yan F., Shin J., Lapalombella R., Hertlein E., Lustberg M.E., Quinion C., Zhang X., Lozanski G., Mu-thusamy N., Praetorius-Ibba M., O'Connor O.A., Goldenberg D.M., Byrd J.C., Blum K.A., Baiocchi R.A.: Combination anti-CD74 (mila-tuzumab) and anti-CD20 (rituximab) monoclonal antibody thera-py has in vitro and in vivo activity in mantle cell lymphoma. Blood, 2011; 117: 4530-4541
2. Amaravadi R.K., Winkler J.D.: Lys05: A new lysosomal autophagy inhibitor. Autophagy, 2012; 8: 1383-1384
3. Anbalagan S., Pires I.M., Blick C., Hill M.A., Ferguson D.J., Chan D.A., Hammond E.M.: Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy. Radiother. Oncol., 2012; 103: 388-393
4. Banerji V., Gibson S.B.: Targeting metabolism and autophagy in the context of haematologic malignancies. Int. J. Cell Biol., 2012; 2012: 595976
5. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouysségur J., Mazure N.M.: Hypoxia-induced autophagy is me-diated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol., 2009; 29: 2570-2581
6. Boya P., Kroemer G.: Beclin 1: A BH3-only protein that fails to induce apoptosis. Oncogene, 2009; 28: 2125-2127
7. Cao Y., Klionsky D.J.: Physiological functions of Atg6/Beclin 1: A unique autophagy-related protein. Cell Res., 2007; 17: 839-849
8. Carew J.S., Kelly K.R., Nawrocki S.T.: Autophagy as a target for can-cer therapy: New developments. Cancer Manag. Res., 2012; 4: 357-365
9. Corona G., Rizzolio F., Giordano A., Toffoli G.: Pharmaco-metab-olomics: An emerging "omics" tool for the personalization of anti-cancer treatments and identification of new valuable therapeutic targets. J. Cell. Physiol., 2012; 227: 2827-2831
10. Czaja J.M.: Functions of autophagy in hepatic and pancreat-ic physiology and disease. Gastroenterology, 2011; 140: 1895-1908
11. Chen N., Debnath J.: Autophagy and tumorigenesis. FEBS Lett., 2010; 584: 1427-1435
12. Dai Z.J., Gao J., Kang H.F., Ma Y.G., Ma X.B., Lu W.F., Lin S., Ma H.B., Wang X.J., Wu W.Y.: Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic car-cinoma cells. Drug Des. Devel. Ther., 2013; 7: 149-159
13. Decuypere J.P., Bultynck G., Parys J.B.: A dual role for Ca2+ in autophagy regulation. Cell Calcium, 2011; 50: 242-250
14. Erenpreisa J., Huna A., Salmina K., Jackson T.R., Cragg M.S.: Macroautophagy-aided elimination of chromatin: Sorting of waste, sorting of fate? Autophagy, 2012; 8: 1877-1881
15. Fu L.L., Cheng Y., Liu B.: Beclin-1: Autophagic regulator and ther-apeutic target in cancer. Int. J. Biochem. Cell Biol., 2013; 45: 921-924
16. Fujita N., Matsunaga K., Noda T., Yoshimori T.: Molecular mecha-nism of autophagosome formation in mammalian cells. Tanpakushit-su Kakusan Koso, 2008; 53 (Suppl. 16): 2106-2110
17. Gammoh N., Marks P.A., Jiang X.: Curbing autophagy and his-tone deacetylases to kill cancer cells. Autophagy, 2012; 8: 1521-1522
18. García-Mauriño S., Alcaide A., Domínguez C.: Pharmacological control of autophagy: Therapeutic perspectives in inflammatory bowel disease and colorectal cancer. Curr. Pharm. Des., 2012; 18: 3853-3873
19. Giannopoulou E., Antonacopoulou A., Matsouka P., Kalofonos H.P.: Autophagy: Novel action of panitumumab in colon cancer. An-ticancer Res., 2009; 29: 5077-5082
20. Giansanti V., Torriglia A., Scovassi A.I.: Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis, 2011; 16: 321-333
21. Guo X.L., Li D., Sun K., Wang J., Liu Y., Song J.R., Zhao Q.D., Zhang S.S., Deng W.J., Zhao X., Wu M.C., Wei L.X.: Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma. J. Mol. Med., 2013; 91: 473-483
22. Harrison S.J., Bishton M., Bates S.E., Grant S., Piekarz R.L., John-stone R.W., Dai Y., Lee B., Araujo M.E., Prince H.M.: A focus on the preclinical development and clinical status of the histone deacety-lase inhibitor, romidepsin (depsipeptide, Istodax®) Epigenomics, 2012; 4: 571-589
23. Hay N., Sonenberg N.: Upstream and downstream of mTOR. Genes Dev., 2004; 18: 1926-1945
24. Jaeger P.A., Wyss-Coray T.: Beclin 1 complex in autophagy and Alzheimer disease. Arch. Neurol., 2010; 67: 1181-1184
25. Jain K., Paranandi K.S., Sridharan S., Basu A.: Autophagy in breast cancer and its implications for therapy. Am. J. Cancer Res., 2013; 3: 251-265
26. Jia L., Gopinathan G., Sukumar J.T., Gribben J.G.: Blocking au-tophagy prevents bortezomib-induced NF-B activation by reduc-ing I-?Bα degradation in lymphoma cells. PLoS One, 2012; 7: 32584
27. Jia W., Pua H.H., Li Q.J., He Y.W.: Autophagy regulates endoplas-mic reticulum homeostasis and calcium mobilization in T lympho-cytes. J. Immunol., 2011; 186: 1564-1574
28. Kang R., Zeh H.J., Lotze M.T., Tang D.: The Beclin 1 network reg-ulates autophagy and apoptosis. Cell Death Differ., 2011; 18: 571-580
29. Kimmelman A.C.: The dynamic nature of autophagy in cancer. Genes Dev., 2011; 25: 1999-2010
30. Knizhnik A.V., Roos W.P., Nikolova T., Quiros S., Tomaszowski K.H., Christmann M., Kaina B.: Survival and death strategies in gli-oma cells: Autophagy, senescence and apoptosis triggered by a sin-gle type of temozolomide-induced DNA damage. PLoS One, 2013; 8: E55665
31. Kohli L., Kaza N., Coric T., Byer S.J., Brossier N.M., Klocke B.J., Bjornsti M.A., Carroll S.L., Roth K.A.: 4-hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res., 2013; 73: 4395-4405
32. Kost A., Kasprowska D., Labuzek K., Wiaderkiewicz R., Gabry-el B.: Autophagy in brain ischemia. Postępy Hig. Med. Dos̈w., 2011; 65: 524-533
33. Koukourakis M.I., Giatromanolaki A., Sivridis E., Pitiakoudis M., Gatter K.C., Harris A.L.: Beclin 1 over - And underexpression in colorectal cancer: Distinct patterns relate to prognosis and tumour hypoxia. Br. J. Cancer, 2010; 103: 1209-1214
34. Kuroda J., Shimura Y., Yamamoto-Sugitani M., Sasaki N., Tani-waki M.: Multifaceted mechanisms for cell survival and drug targe-ting in chronic myelogenous leukemia. Curr. Cancer Drug Targets, 2013; 13: 69-79
35. Lachenmayer A., Toffanin S., Cabellos L., Alsinet C., Hoshida Y., Villanueva A., Minguez B., Tsai H.W., Ward S.C., Thung S., Friedman S.L., Llovet J.M.: Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J. Hepatol., 2012; 56: 1343-1350
36. Lee S.J., Kim H.P., Jin Y., Choi A.M., Ryter S.W.: Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Auto-phagy, 2011; 7: 829-839
37. Lefranc F., Facchini V., Kiss R.: Proautophagic drugs: A novel me-ans to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist, 2007; 12: 1395-1403
38. Levine B., Kroemer G.: Autophagy in aging, disease and death: The true identity of a cell death impostor. Cell Death Differ., 2009; 16: 1-2
39. Levine B., Mizushima N., Virgin H.W.: Autophagy in immunity and inflammation. Nature, 2011; 469: 323-335
40. Levine B., Sinha S., Kroemer G.: Bcl-2 family members: Dual re-gulators of apoptosis and autophagy. Autophagy, 2008; 4: 600-606
41. Li Z., Chen B., Wu Y., Jin F., Xia Y., Liu X.: Genetic and epigene-tic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer, 2010; 10: 98
42. Liang C., Feng P., Ku B., Dotan I.,Canaani D., Oh B.H., Jung J.U.: Autophagic and tumour suppressor activity of a novel Beclin1-bin-ding protein UVRAG. Nat. Cell Biol., 2006; 8: 688-699
43. Lin C.I., Whang E.E., Lorch J.H., Ruan D.T.: Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer. Surgery, 2012; 152: 1142-1149
44. Liu B., Cheng Y., Liu Q., Bao J.K., Yang J.M.: Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sin., 2010; 31: 1154-1164
45. Lockshin R.A., Zakeri Z.: Apoptosis, autophagy, and more. Int. J. Biochem. Cell Biol., 2004; 36: 2405-2419
46. Mancias J.D., Kimmelman A.C.: Targeting autophagy addiction in cancer. Oncotarget, 2011; 2: 1302-1306
47. Martyniszyn L., Orlowski P., Krzyżowska M., Niemialtowski M.G.: Autofagia w zakażeniach wirusowych i bakteryjnych: Molekularna ruletka. Postępy Biol. Kom., 2008; 35: 351-368
48. Martyniszyn L., Szulc L., Boratyńska A., Niemialtowski M.G.: Beclin 1 is involved in regulation of apoptosis and autophagy du-ring replication of ectromelia virus in permissive L929 cells. Arch. Immunol. Ther. Exp., 2011; 59: 463-471
49. Maycotte P., Thorburn A.: Autophagy and cancer therapy. Can-cer Biol. Ther., 2011; 11: 127-137
50. Mehrpour M., Esclatine A., Beau I., Codogno P.: Autophagy in health and disease. 1. Regulation and significance of autophagy: An overview. Am. J. Physiol. Cell Physiol., 2010; 298: C776-C785
51. Mizushima N.: Autophagy: Process and function. Genes Dev., 2007; 21: 2861-2873
52. Mizushima N., Levine B.: Autophagy in mammalian development and differentiation. Nat. Cell Biol., 2010; 12: 823-830
53. Mizushima N., Ohsumi Y., Yoshimori T.: Autophagosome for-mation in mammalian cells. Cell Struct. Funct., 2002; 27: 421-429
54. Morselli E., Galluzzi L., Kepp O., Criollo A., Maiuri M.C., Tav-ernarakis N., Madeo F., Kroemer G.: Autophagy mediates pharma-cological lifespan extension by spermidine and resveratrol. Aging, 2009; 1: 961-970
55. Notte A., Leclere L., Michiels C.: Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol., 2011; 82: 427-434
56. Perycz M., ͆wiech L., Malik A., Jaworski J.: MTOR w fizjologii i patologii ukladu nerwowego. Postępy Biol. Kom., 2007; 34: 511-525
57. Qu X., Zou Z., Sun Q., Luby-Phelps K., Cheng P., Hogan R.N., Gilpin C., Levine B.: Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell, 2007; 128: 931-946
58. Reggiori F., Shintani T., Nair U., Klionsky D.J.: Atg9 cycles be-tween mitochondria and the pre-autophagosomal structure in yeasts. Autophagy, 2005; 1: 101-109
59. Rikiishi H.: Autophagic action of new targeting agents in head and neck oncology. Cancer Biol. Ther., 2012; 13: 978-991
60. Rosenfeldt M.T., Ryan K.M.: The multiple roles of autophagy in cancer. Carcinogenesis, 2011; 32: 955-963
61. Rosich L., Xargay-Torrent S., López-Guerra M., Campo E., Co-lomer D., Roué G.: Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma. Clin. Cancer Res., 2012; 18: 5278-5289
62. Roy S., Debnath J.: Autophagy and tumorigenesis. Semin. Im-munopathol., 2010; 32: 383-396
63. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J.: Po-tential therapeutic applications of autophagy. Nat. Rev. Drug Dis-cov., 2007; 6: 304-312
64. Schwartz-Roberts J.L., Shajahan A.N., Cook K.L., Wärri A., Abu-Asab M., Clarke R.: GX15-070 (obatoclax) induces apoptosis and inhib-its cathepsin D - And L-mediated autophagosomal lysis in antiestro-gen-resistant breast cancer cells. Mol. Cancer Ther., 2013; 12: 448-459
65. Sridharan S., Basu A.: S6 kinase 2 promotes breast cancer cell survival via Akt. Cancer Res., 2011; 71: 2590-2599
66. Subauste C.S.: Autophagy as an antimicrobial strategy. Expert Rev. Anti Infect. Ther., 2009; 7: 743-752
67. Sun Q., Fan W., Zhong Q.: Regulation of Beclin 1 in autophagy. Autophagy, 2009; 5: 713-716
68. Suzuki K., Kubota Y., Sekito T., Ohsumi Y.: Hierarchy of Atg pro-teins in pre-autophagosomal structure organization. Genes Cells, 2007; 12: 209-218
69. Tanida I., Ueno T., Kominami E.: LC3 and autophagy. Methods Mol. Biol., 2008; 445: 77-88
70. Tasdemir E., Chiara Maiuri M., Morselli E., Criollo A., D'Amelio M., Djavaheri-Mergny M., Cecconi F., Tavernarakis N., Kroemer G.: A dual role of p53 in the control of autophagy. Autophagy, 2008; 4: 810-814
71. Tooze S.A., Yoshimori T.: The origin of the autophagosomal membrane. Nat. Cell Biol., 2010: 12: 831-835
72. Turcotte S., Giaccia A.J.: Targeting cancer cells through autoph-agy for anticancer therapy. Curr. Opin. Cell Biol., 2010; 22: 246-251
73. Wang C., Wang Y., McNutt M.A., Zhu W.G.: Autophagy process is associated with anti-neoplastic function. Acta Biochim. Biophys. Sin., 2011; 43: 425-432
74. Weidberg H., Shpilka T., Shvets E., Elazar Z.: Mammalian Atg8s: One is simply not enough. Autophagy, 2010; 6: 808-809
75. Weidberg H., Shvets E., Elazar Z.: Biogenesis and cargo selec-tivity of autophagosomes. Annu. Rev. Biochem., 2011; 80: 125-156
76. Wu W.K., Coffelt S.B., Cho C.H., Wang X.J., Lee C.W., Chan F.K., Yu J., Sung J.J.: The autophagic paradox in cancer therapy. Onco-gene, 2012; 31: 939-953
77. Yang Y.P., Liang Z.Q., Gu Z.L., Qin Z.H.: Molecular mechanism and regulation of autophagy. Acta Pharmacol. Sin., 2005; 26: 1421-1434
78. Yang Z., Klionsky D.J.: Mammalian autophagy: Core molecular machinery and signaling regulation. Curr. Opin. Cell Biol., 2010; 22: 124-131
79. Zang Y., Thomas S.M., Chan E.T., Kirk C.J., Freilino M.L., DeLanc-ey H.M., Grandis J.R., Li C., Johnson D.E.: The next generation pro-teasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4. Autophagy, 2012; 8: 1873-1874
80. Zhu K., Dunner K.Jr., McConkey D.J.: Proteasome inhibitors ac-tivate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene, 2010; 29: 451-462
81. Zhu X., Wu L., Qiao H., Han T., Chen S., Liu X., Jiang R., Wei Y., Feng D., Zhang Y., Ma Y., Zhang S., Zhang J.: Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapati-nib. J. Cell. Biochem., 2013; 114: 2643-2653